These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. Wagle N; Emery C; Berger MF; Davis MJ; Sawyer A; Pochanard P; Kehoe SM; Johannessen CM; Macconaill LE; Hahn WC; Meyerson M; Garraway LA J Clin Oncol; 2011 Aug; 29(22):3085-96. PubMed ID: 21383288 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel complex BRAF mutation associated with major clinical response to vemurafenib in a patient with metastatic melanoma. Busser B; Leccia MT; Gras-Combe G; Bricault I; Templier I; Claeys A; Richard MJ; de Fraipont F; Charles J JAMA Dermatol; 2013 Dec; 149(12):1403-6. PubMed ID: 24108467 [TBL] [Abstract][Full Text] [Related]
15. BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel. Gonzalez D; Fearfield L; Nathan P; Tanière P; Wallace A; Brown E; Harwood C; Marsden J; Whittaker S Br J Dermatol; 2013 Apr; 168(4):700-7. PubMed ID: 23360189 [TBL] [Abstract][Full Text] [Related]